相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detecting and predicting neutralization of alemtuzumab responses in MS
Gauri Saxena et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
Jamie Brannigan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Lack of CD4+T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses
Simona Rolla et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
David Baker et al.
JAMA NEUROLOGY (2017)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
分享论文
